Mosaic ImmunoEngineering Depreciation & Amortization Growth & History (CPMV)
Mosaic ImmunoEngineering's depreciation and amortization was $488 for fiscal 2020.
View full Mosaic ImmunoEngineering company overviewMosaic ImmunoEngineering annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2020 · May 31 | 2020-05-31 | $488 | −$1 | −0.20% |
| 2019 | 2019-05-31 | $489 | −$274 | −35.91% |
| 2018 | 2018-05-31 | $763 | −$63 | −7.63% |
| 2017 | 2017-05-31 | $826 | −$472 | −36.36% |
| 2016 | 2016-05-31 | $1,298 | −$756 | −36.81% |
| 2015 | 2015-05-31 | $2,054 | −$249 | −10.81% |
| 2014 | 2014-05-31 | $2,303 | −$287 | −11.08% |
| 2013 | 2013-05-31 | $2,590 | −$601 | −18.83% |
| 2012 | 2012-05-31 | $3,191 | −$6,175 | −65.93% |
| 2011 | 2011-05-31 | $9,366 | — | — |
Mosaic ImmunoEngineering quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2020 | 2020-02-29 | $122 | $0 | 0.00% |
| Q2 2020 · Nov 30 | 2019-11-30 | $122 | $0 | 0.00% |
| Q1 2020 | 2019-08-31 | $122 | $0 | 0.00% |
| Q3 2019 | 2019-02-28 | $122 | −$69 | −36.13% |
| Q2 2019 | 2018-11-30 | $122 | −$103 | −45.78% |
| Q1 2019 | 2018-08-31 | $122 | −$103 | −45.78% |
| Q3 2018 | 2018-02-28 | $191 | −$35 | −15.49% |
| Q2 2018 | 2017-11-30 | $225 | $0 | 0.00% |
| Q1 2018 | 2017-08-31 | $225 | $75 | +50.00% |
| Q3 2017 | 2017-02-28 | $226 | −$76 | −25.17% |
| Q2 2017 | 2016-11-30 | $225 | −$233 | −50.87% |
| Q1 2017 | 2016-08-31 | $150 | −$327 | −68.55% |
| Q3 2016 | 2016-02-29 | $302 | −$136 | −31.05% |
| Q2 2016 | 2015-11-30 | $458 | −$146 | −24.17% |
| Q1 2016 | 2015-08-31 | $477 | −$58 | −10.84% |
| Q3 2015 | 2015-02-28 | $438 | −$138 | −23.96% |
| Q2 2015 | 2014-11-30 | $604 | $28 | +4.86% |
| Q1 2015 | 2014-08-31 | $535 | −$41 | −7.12% |
| Q3 2014 | 2014-02-28 | $576 | −$55 | −8.72% |
| Q2 2014 | 2013-11-30 | $576 | −$61 | −9.58% |
| Q1 2014 | 2013-08-31 | $576 | −$90 | −13.51% |
| Q3 2013 | 2013-02-28 | $631 | −$166 | −20.83% |
| Q2 2013 | 2012-11-30 | $637 | −$1,871 | −74.60% |
| Q1 2013 | 2012-08-31 | $666 | −$1,840 | −73.42% |
| Q3 2012 | 2012-02-29 | $797 | — | — |
| Q2 2012 | 2011-11-30 | $2,508 | −$72,625 | −96.66% |
| Q1 2012 | 2011-08-31 | $2,506 | −$72,627 | −96.66% |
| Q2 2011 | 2010-11-30 | $75,133 | — | — |
| Q1 2011 | 2010-08-31 | $75,133 | — | — |
Mosaic ImmunoEngineering depreciation and amortization trends
Over the last five fiscal years, Mosaic ImmunoEngineering's depreciation and amortization decreased from $2,054 to $488, a change of −$1,566. The latest reported quarter, Q3 2020, shows $122.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mosaic ImmunoEngineering source filings ↗